. TβRI then phosphorylates Smad2 and Smad3 in their C-terminal region which enables heterocomplex formation with Smad4 and subsequent translocation to the nucleus where they act as transcription factors binding to TGF-β responsive genes 8, 9 . The canonical TGF-β-mediated Smad2/3 C-terminal phosphorylation is important in many TGF-β responses including biglycan synthesis and GAG chain elongation in VSM 4 .
However it has also been established that TGF-β can mediate pathways other than the canonical Smad pathway to generate proteoglycan synthesis. TGF-β-mediated phosphorylation of Smad2 linker region, described in the literature as a non-Smad pathway despite the integral role of Smad, has been shown to lead to activation of the ERK and p38 MAP kinase signalling pathways and results in biglycan synthesis and GAG elongation in human VSMCs Recently TGF-β signalling has been shown to involve Akt via activation of the PI3K-Akt-TOR-S6 kinase pathway in cells undergoing epithelial to mesenchymal transition 11 . This activation has been shown to be independent of Smad2/3 in fibroblasts 12 .
Akt, also referred to as PKB, plays a key role in regulating cell survival and apoptosis 13, 14 . This protein kinase is activated by insulin and various growth factors in a wortmannin-sensitive pathway involving PI3 kinase 14 . Akt binds phospholipid and is activated by phosphorylation by PDK1 at Thr308 in the activation loop and by PDK2 at Ser473 at the carboxy terminus Clearly Akt has key roles in EMT, cell cycle regulation, cell growth and cell survival in many cell types. TGF-β-mediated activation of PI3K/Akt pathway can complement or antagonize Smad-mediated effects depending on cell type and context. In this study we have investigated whether TGF-β can activate Akt and its requirement for Smad in biglycan synthesis in human VSMCs.
Materials and methods

Materials
The following chemicals were purchased from Sigma, (St Louis, MO, USA): benzamidine hydrochloride, DEAE-Sephacel, Sepharose CL-6B, proteinase K, chondroitin sulfate, SB431542, PDGF, thrombin and penicillin-streptomycin. 
Culture of human VSMC
Human VSMCs were prepared by the explant method as previously described 25 using otherwise discarded sections of the internal mammary artery and saphenous veins from patients undergoing coronary artery bypass grafting at Alfred Health, Melbourne, Australia. The acquisition of the vessel segments was approved by the Alfred Hospital Ethics committee. VSMC were grown in Dulbecco's modified eagle medium (DMEM) with 5mM glucose, 10% FBS and 1% penicillin-streptomycin solution. For experimentation, VSMC were seeded into 24 well plates (proteoglycan experiments) or 60 mm diameter plates (Western blotting experiments), grown until confluency then serum starved (0.1% FCS) for 48 h before experimentation as described.
Western blotting
Total cell lysates were resolved on 10% SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with 5% skim milk powder, incubated with primary antibodies as detailed in the text followed by HRP-anti-rabbit IgG and ECL detection (Amersham). Blots were quantified by densitometry using QuantityOne software (BioRad). Primary antibodies used in this study were anti-phosphoSmad2/3C rabbit monoclonal antibody, anti-phosphoSmad2L, antibody anti-phosphoAkt 
SDS-PAGE analysis of proteoglycan size
Proteoglycans labelled with [ PAGE by isolation through DEAE sephacel anionic exchange mini columns. Samples were added to pre-equilibrated columns, then washed extensively with low salt buffer (8M Urea, 0.25M NaCl, 2 mM disodium EDTA, 0.5% Triton X-100). Proteoglycans were eluted with high salt buffer (8M Urea, 3M NaCl, 2mM disodium EDTA, 0.5% Triton X-100) Aliquots (25,000 cpm) were precipitated (1.3% potassium acetate, 95% ethanol) and chondroitin sulfate was added as a cold carrier. Samples were resuspended in buffer (8M Urea, 2mM disodium EDTA, pH 7.5), to which an equal volume of sample buffer was added. Radiolabelled proteoglycans were separated on 4-13% acrylamide gels with a 3% stacking gel at 50V overnight. 
Determination of the expression of biglycan by RT-PCR
Human VSMCs cells were plated on 6-well culture plate pre-coated with 10 ug/ml poly-D-lysine and fed with DMEM medium supplemented with 1% FBS, plus antibiotics in 5% CO2 at 37 o C. The following day medium was replaced with DMEM alone for 1h then the cells were treated with TGFβ (2ng/ml) for different times as indicated to observe the effect of TGFβ on the expression of biglycan. In experiments using inhibitors, cells were pre-incubated with or without SN30978 (5 µM) or SB431542 (3µM) for 30min, and then treated with TGF-β (2ng/ml) for 24 hours.
Total RNAs were extracted from treated cells using TRIZOL Reagent (TIANGEN Corp.). First-strand cDNA was synthesized from 1.5 μg total RNA with random primer and M-MLV RTase (Genecopoeia Corp.); Resulting cDNA were subjected to PCR amplification using specific primers (sense primer, 5'-CTCCTCCAGGTGGTCTATC-3'and antisense primer, 5'-GCTGATGCCGTTGTAGTAG-3') for biglycan. Products of PCR were electrophoresed on a 1.5% agarose gel.
Statistical analyses
Data was analysed for statistical significance using a 1-way analysis of variance (ANOVA) or a Student's paired t-test as stated. Results were considered statistically significant at P<0.05 or better as stated.
Results
TGF-β causes rapid phosphorylation of Akt in human VSMCs
To determine whether TGF-β can elicit phosphorylation of Akt in VSMCs we treated serum-deprived human VSMCs with TGF-β (2 ng/ml) for 0 -4h and then probed a 
TGF-β-mediated Smad2 phosphorylation is independent of Akt stimulation
Smad-independent TGF-β signalling of PI3K has been reported in fibroblasts 12 and here we investigated whether blocking phosphorylation of Akt would interfere with the known pathway of TGF-β/carboxy terminal and linker region phosphorylation of . TGF-β induces TβRI to directly phosphorylate the two distal serines of Smad C-terminal SSXS motif and indirectly cause MAP kinases to phosphorylate serine and threonine residues in Smad linker region 8 . Western blots using antipSmad2C showed a significant increase (4.6-fold) in pSmad2C levels following TGF-β treatment ( Figure 3A and 3B ). PDGF and thrombin showed a small increase in pSmad2C levels above basal the latter similar to our published findings 31 . Blocking -10 -Akt phosphorylation had no effect on pSmad2C levels after stimulation with any of the agonists ( Figure 3A) . TGF-β treatment increased the level of Smad2 linker region phosphorylation approximately 5-fold compared to a 2-fold or less increase after PDGF or thrombin stimulation respectively ( Figure 3B ). Similarly to pSmad2C we observed no change in the levels of pSmad2L when Akt phosphorylation was blocked with SN30978 ( Figure 3B ). The inability of the Akt inhibitor to block Smad phosphorylation indicates that neither carboxy nor linker region Smad2 phosphorylation are downstream of Akt and in this context are likely independent of PI3K activation.
TGF-β stimulates biglycan core protein synthesis via Akt
To determine whether Akt is a component of TGF-β-mediated proteoglycan synthesis in human VSMCs we performed experiments with the Akt1/2 inhibitor SN30978 on Cells were untreated (-) or pre-treated for 30 min with the Akt1/2 inhibitor SN30978 (2 µM) and then stimulated with (A) TGF-β (2 ng/ml) for either 15 min or 4 h, or PDGF (50 ng/ml) for 1 h (B) Thrombin (10 Units/ml), PDGF (50 ng/ml) or TGF-β (2 ng/ml) for 1 h. Cells pre-treated for 30 min with TβRI kinase inhibitor SB431542 (3 µM) (SB) were stimulated with TGF-β (2 ng/ml) for 1 h. Cell lysates were processed and probed for phospho-Akt, Akt and GAPDH as described. Density analysis using Biorad Quantity One software is shown to the right of each blot, ## P<0.01 vs control, ** P<0.01 vs agonist, # P<0.05 vs control
Figure 3 Role of Akt in TGF-β-mediated Smad pathway
Cells were untreated (-) or pre-treated for 30 min with the Akt1/2 inhibitor SN30978 (2 µM) and then stimulated with Thrombin (10 Units/ml), PDGF (50 ng/ml) or TGF-β (2 ng/ml) for 1 h. Cells pre-treated for 30 min with TβRI kinase inhibitor SB431542 (3 µM) (SB) were stimulated with TGF-β (2 ng/ml) for 1 h. Cell lysates were
